Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


May 30, 2015 1:36 PM ET

Pharmaceuticals

Company Overview of Paratek Pharmaceuticals, Inc.

Executive Profile

Glenn A. Oclassen Sr.

Former Chief Executive Officer, President and Director, Paratek Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 3 different industries.

See Board Relationships
71$1,830,280
As of Fiscal Year 2014

Background

Mr. Glenn A. Oclassen, Sr. served as the Chief Executive Officer and President of Transcept Pharmaceuticals, Inc. (TPI) since July 2003 and its Chairman of the Board since December 31, 2013. Mr. Oclassen serves as Consultant of Connetics Corporation. He served as Chief Executive Officer and President at Paratek Pharmaceuticals, Inc. until October 30, 2014. He served as Venture Partner of Montreux Equity Partners, Montreux Equity Partners II, Montreux Equity Partners ...

Corporate Headquarters

75 Kneeland Street
Boston, Massachusetts 02111

United States

Phone: 617-275-0040
Fax: 617-275-0039

Board Members Memberships

Former Chief Executive Officer, President and Director
Director
1999-N/A
Former Director
2003-N/A
Chairman of the Board, Chief Executive Officer and President

Education

BS 1965
San Diego State University

Other Affiliations

Annual Compensation

Salary$466,667
Bonus$280,000
Total Annual Compensation$746,667

Stocks Options

All Other Compensation$1,083,613

Total Compensation

Total Annual Cash Compensation$1,830,280
Total Short Term Compensation$746,667
Other Long Term Compensation$1,083,613
Total Calculated Compensation$1,830,280
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Paratek Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.